345 related articles for article (PubMed ID: 16647451)
21. Proteinuria after conversion to sirolimus in renal transplant recipients.
Sahin GM; Sahin S; Kantarci G; Ergin H
Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308
[TBL] [Abstract][Full Text] [Related]
22. Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia--a case report.
Pascual J; Fernández AM; Marcén R; Ortuño J
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii38-41. PubMed ID: 16815857
[TBL] [Abstract][Full Text] [Related]
23. Conversion to a proliferation signal inhibitor in a patient with coronary artery disease--a case report.
Sparacino V; Calabrese S
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii34-7. PubMed ID: 16815856
[TBL] [Abstract][Full Text] [Related]
24. An unusual presentation of sirolimus associated cough in a renal transplant recipient.
Adibelli Z; Dilek M; Kocak B; Tülek N; Uzun O; Akpolat T
Transplant Proc; 2007 Dec; 39(10):3463-4. PubMed ID: 18089408
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.
Celik S; Doesch A; Erbel C; Blessing E; Ammon K; Koch A; Katus HA; Dengler TJ
Transplantation; 2008 Jul; 86(2):245-50. PubMed ID: 18645486
[TBL] [Abstract][Full Text] [Related]
26. Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation.
Carreño CA; Gadea M
Transplant Proc; 2007 Apr; 39(3):594-5. PubMed ID: 17445552
[TBL] [Abstract][Full Text] [Related]
27. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.
Garrean S; Massad MG; Tshibaka M; Hanhan Z; Caines AE; Benedetti E
Clin Transplant; 2005 Oct; 19(5):698-703. PubMed ID: 16146565
[TBL] [Abstract][Full Text] [Related]
28. Initial single-center experience with sirolimus after lung transplantation.
Lischke R; Simonek J; Matousovic K; Stolz AJ; Schützner J; Vojácek J; Burkert J; Davidová R; Pafko P
Transplant Proc; 2006 Nov; 38(9):3006-11. PubMed ID: 17112886
[TBL] [Abstract][Full Text] [Related]
29. Sirolimus-induced pneumonitis complicated by pentamidine-induced phospholipidosis in a renal transplant recipient: a case report.
Filippone EJ; Carson JM; Beckford RA; Jaffe BC; Newman E; Awsare BK; Doria C; Farber JL
Transplant Proc; 2011 Sep; 43(7):2792-7. PubMed ID: 21911165
[TBL] [Abstract][Full Text] [Related]
30. Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience.
Li JT; Danguilan RA; Cabanayan-Casasola CB; Talusan-Tomacruz Y; Ona ET
Transplant Proc; 2008 Sep; 40(7):2211-3. PubMed ID: 18790195
[TBL] [Abstract][Full Text] [Related]
31. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
32. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
Falger JC; Mueller T; Arbeiter K; Boehm M; Regele H; Balzar E; Aufricht C
Pediatr Transplant; 2006 Aug; 10(5):565-9. PubMed ID: 16856992
[TBL] [Abstract][Full Text] [Related]
33. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
De Simone P; Metselaar HJ; Fischer L; Dumortier J; Boudjema K; Hardwigsen J; Rostaing L; De Carlis L; Saliba F; Nevens F
Liver Transpl; 2009 Oct; 15(10):1262-9. PubMed ID: 19790150
[TBL] [Abstract][Full Text] [Related]
34. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.
Tenderich G; Fuchs U; Zittermann A; Muckelbauer R; Berthold HK; Koerfer R
Clin Transplant; 2007; 21(4):536-43. PubMed ID: 17645716
[TBL] [Abstract][Full Text] [Related]
35. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up.
Rothenburger M; Teerling E; Bruch C; Lehmkuhl H; Suwelack B; Bara C; Wichter T; Hinder F; Schmid C; Stypmann J
J Heart Lung Transplant; 2007 Mar; 26(3):250-7. PubMed ID: 17346627
[TBL] [Abstract][Full Text] [Related]
36. Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options.
Schrader J; Sterneck M; Klose H; Lohse AW; Nashan B; Fischer L
Transpl Int; 2010 Jan; 23(1):110-3. PubMed ID: 19497063
[No Abstract] [Full Text] [Related]
37. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction.
Ruiz JC; Campistol JM; Sánchez-Fructuoso A; Rivera C; Oliver J; Ramos D; Campos B; Arias M; Diekmann F
Nephrol Dial Transplant; 2006 Nov; 21(11):3252-7. PubMed ID: 16954170
[TBL] [Abstract][Full Text] [Related]
38. Reversible sirolimus-associated pneumonitis after heart transplantation.
Hamour IM; Mittal TK; Bell AD; Banner NR
J Heart Lung Transplant; 2006 Feb; 25(2):241-4. PubMed ID: 16446228
[TBL] [Abstract][Full Text] [Related]
39. Sirolimus-associated interstitial pneumonitis in 3 heart transplant recipients.
Delgado JF; Torres J; José Ruiz-Cano M; Sánchez V; Escribano P; Borruel S; María Cortina J; de la Calzada CS
J Heart Lung Transplant; 2006 Sep; 25(9):1171-4. PubMed ID: 16962483
[TBL] [Abstract][Full Text] [Related]
40. Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships.
Kovarik JM; Snell GI; Valentine V; Aris R; Chan CK; Schmidli H; Pirron U
J Heart Lung Transplant; 2006 Apr; 25(4):440-6. PubMed ID: 16563975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
